Clinical Trials
4 trialsNCT00053365 2019-07-24
Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00019552 2013-06-20
Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00005070 2013-06-19
Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00005031 2013-05-27
Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
GOG Foundation
Phase 2 Completed